UK markets closed

PharmaSGP Holding SE (PSGD.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
22.30-6.50 (-22.57%)
At close: 04:28PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
107,293
101,099
85,824
65,344
63,246
Cost of revenue
9,735
9,462
9,032
6,488
6,206
Gross profit
97,558
91,637
76,792
58,856
57,040
Operating expenses
Selling general and administrative
46,361
43,381
37,378
30,843
34,593
Total operating expenses
71,297
66,999
59,109
43,937
40,966
Operating income or loss
26,261
24,638
17,683
14,919
16,074
Interest expense
4,451
4,410
2,007
642
75
Income before tax
24,117
21,893
15,803
14,206
14,149
Income tax expense
6,006
5,496
3,849
3,516
3,509
Income from continuing operations
18,111
16,397
11,954
10,690
10,640
Net income
18,111
16,397
11,954
10,690
10,640
Net income available to common shareholders
18,111
16,397
11,954
10,690
10,640
Basic EPS
1.25
1.37
1.00
0.89
0.89
Diluted EPS
1.25
1.37
1.00
0.89
0.89
Basic average shares
12,036
11,993
12,000
12,000
12,000
Diluted average shares
12,036
11,993
12,000
12,000
12,000